Allegations Mount Against DEA Leadership Over Unsafe Cannabis Markets and Blocked Research
A recent report has cast a critical light on the oversight – or lack thereof – within the burgeoning state-legal cannabis markets and the federal approach to cannabis research. Central to the allegations is the performance of the Drug Enforcement Administration (DEA), and specifically its Deputy Administrator Thomas Prevoznik, who heads the agency’s Diversion Control…